+ All Categories
Home > Documents > Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre...

Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre...

Date post: 16-Jan-2016
Category:
Upload: piers-robinson
View: 220 times
Download: 0 times
Share this document with a friend
Popular Tags:
42
Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency
Transcript
Page 1: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

Pathways of technology adoption and adaptation

Saheer GharbiaApplied and Functional Genomics

Centre for InfectionHealth Protection Agency

Page 2: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

Methods and approaches to elucidate the spread of infectious diseases are as old as human civilisation and stretch in their logic from magical, philosophical to scientific.

Page 3: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

Pheno-, Sero-, phage and biotypes

extremely valuable, able to identify cellular

components associated with virulence.Limited discriminatory power, resolving

pathogens into only a few types.Challenged by Diversity, mutations and

acquisition of new traits

Page 4: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

Technology in diagnostics is a composite of:

•Refining what is established•Exploring what is new (concept or tool)•Adapting the new to the function

Page 5: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

Examples of Streamlining:

VIDAS®: automated system for Rapid Pathogen Monitoring

VITEK® 2 Compact: automated system for microbial identification

API® / ID 32/ APIWEB®: microbial identification with internet-base tool

TEMPO®: enumeration of quality indicators in food

air IDEAL®: aerobiocontamination control

Count-Tact™ range: monitoring of surface and air biocontamination

BacT/ALERT® 3D microbial detection system

Multiplex Fluorescent Immunoassay

RaPET Rapid Particle Enhanced Technology

Page 6: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

Salvador Luria and Max Delbruck (1943)

Provided a statistical demonstration that inheritance in bacteria follows Darwinian principles. Mutations occur randomly in bacterial populations. They occur in small numbers in some populations and in large numbers in other cultures.

awarded the Nobel Prize in Medicine or Physiology in 1969.

Page 7: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

Classical Molecular Genetics for the analysis of infectious agents was a natural follow up especially with the publication of the Watson-Crick DNA model.

Gross DNA structure: Restriction Diget, southern hybridisation, RFLP,AFLP, plasmid profiling, PFGE, fAFLP and ribotyping

Page 8: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

PCR lead to the next phase by accelerating the process, adding higher resolution, selective amplification and quantitative measurements

Page 9: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

The power of PCR-based methods is the ease with which they can be applied to many bacterial pathogens and their multilocus discrimination.

Such methods have proven valuable for genetic dissection of pathogens for which previous methods have failed.

Page 10: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.
Page 11: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

Dendrogram of MroI FAFLP

Page 12: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.
Page 13: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

However, a limitation of many PCR-based approaches is the biallelic (binary) nature of their data resulting from the presence or absence of a marker fragment.

Page 14: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

Draft Microbial Genomes

The first pathogens to be sequenced under the current program are members of the Bacillus, Brucella, Clostridium, Francisella, Shigella, and Yersinia groups. In many of these groups, several strains or related species will be sequenced, for example, two strains of Bacillus anthracis (anthrax) and one of the similar species Bacillus thuringiensis.

Page 15: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.
Page 16: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

Sequence-derived DNA typing is more rapid and has an even greater capacity for genetic dissection of bacterial pathogens. It is limited only by the genome size and the technology.

Because most microbial genomes consist of millions of nucleotides,

technology is invariably limiting.

Page 17: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.
Page 18: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.
Page 19: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.
Page 20: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.
Page 21: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

The flagellum is composed of 20,000 flagellin subunits

• Flagellin subunit is the antigenic determinant

Page 22: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

H antigen typing of Salmonella

Kauffmann-White scheme

• Expression of antigens is determined by agglutination with specific antisera

• In accordance with this scheme, routine clinical laboratories classify Salmonella by their particular combination of flagellar (H) and somatic (O) antigens.

• O antigens (60 have been distinguished)• H1 antigens (63 have been distinguished)• H2 antigens, not always present (37 have been distinguished)

• H-antigens are designated by letters of the alphabet (a, to z, z1, z2 etc.) and by Arabic numerals.

Page 23: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

Identification of unique amino acid motifs

Page 24: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

Sequence distances of fliC of different serotypes

g-complex sequences

“non-g” sequences

Nucleotide Substitutions (x100) 0

68.6

10 20 30 40 50 60

-_gallinarum_M84979 -_pullorum_B51

g,m_enteritidis_B16 g,m_enteritidis_B18 g,m,s_emek_B20 -_gallinarum_M84975 -_gallinarum_M84976 g,m_enteritidis_B17 g,m,[t]_othmarschen_U06455 f,g,m,p_enteritidis g,m_essen_U05299 g,q_moscow_Z15086

g,p_dublin2_M84972 g,p_dublin3_M84973 g,p_dublin1_z15067 g,p_dublin_B12 g,p,u_rostock g,p,s_naestved g,m_enteritidis_B19 g,m,[p],s_montevideo g,m,{p},s_montevideo_B31

[g,s,t]_simsbury g,s,t_senftenberg g,[s],t_B59

g,t_budapest f,g,s_agona_B01 f,g_derby f,g_derby_B09 f,g_adelaide

f,g,t_berta m,t_banana m,t_oranienburg

g,z51_C15 g,z51_C09

g,z51_newmexico r_A37_heidleberg r_A30_heidleberg r_A40_heidleberg r_A32_heidleberg r_A31_heidleberg

i_typhimurium_C01 i_typhimurium_A01 i_typhimurium e,h_anatum_B02

e,h_saintpaul_A22 e,h_newport_B36

c_choleraesuis_B04 c_choleraesuis_AF159459

z41_bongori_C11 z_indiana_B25 z10_hadar z10_haifa_B22

z35_arizonae_C08 k_thompson_B62

l,v_panama_B39 l,v_B03

a_miami_B28 d_muenchen_A63 d_muenchen_X03395 d_duisberg_B15

b_paratyphiB_A41 z4,z24_seminole_C16

z4,z23_stanleyville_B61 z4,z23_arizonae_C05

Page 25: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

4

Pyrosequencing™

PPi

ATP

Page 26: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

Analysis of several SNPs

5’-C/TGGCCGGGTCACGAT/GGCCC-3’

Page 27: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

Identification of H1:g,p vs. H1:g,m

•A test was designed specifically for differentiation between dublin and enteritidis serotypes.

•Based on a SNP in the central variable region.

S. dublin genotype:

S. enteritidis genotype:

Page 28: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.
Page 29: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

•One of the most recent developments in molecular analysis involves the analysis of VNTR sequences.

•Short nucleotide sequences that are repeated multiple times often vary

in copy number, creating length polymorphisms that can be detected

by PCR using flanking primers.

•Satellites: Spanning megabases

•Minisatellites: Repeat units 6-100bp (spans 100’s bps

•Microsatellites: Repeat units 1-5 bp (spans 10’s bps)

Page 30: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

The multi-locus VNTR banding patterns, as originally described by Alec Jeffreys enable us to determine relationships and degrees of relationship between individuals. Bands on the blot may be classified as 'M' for maternal, 'P' for paternal, 'I' for invariant, or 'X' for non-parental.

Page 31: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

VNTR Background

Polymorphism at a VNTR locus can occur either as a result of nucleotide sequence changes between individual repeat units or as a result of variation in the number of repeat units, hence creating allelic variants.

GATCATCGGT

GATCATCGGTCATAGACTATGATC

GATCATCGGTCATAGACTAT

TAGACTAGATAGC

TAGACTAGATAGC

TAGACTAGATAGC

A

A

G

T

Page 32: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

Electrophoretic analysis of VNTR fragments from different B. anthracis isolates

Page 33: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

Capillary Electrophoresis

Page 34: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

VNTR Cluster AnalysisCategorical

VNTR largest x-y

100

50

K@lisademo@00000006

K@lisademo@00000016

K@lisademo@00000003

K@lisademo@00000004

K@lisademo@00000010

K@lisademo@00000013

K@lisademo@00000001

K@lisademo@00000017

K@lisademo@00000008

K@lisademo@00000009

K@lisademo@00000005

K@lisademo@00000007

K@lisademo@00000002

K@lisademo@00000014

K@lisademo@00000011

K@lisademo@00000012

K@lisademo@00000015

18-NCTC_10.

E168704B

16-NCTC_10.

17-NCTC_10.

19-NCTC_10.

Kenya

13-NCTC_59.

E16895B

11-NCTC_20.

10-NCTC_570.

09-NCTC_144.

12-NCTC_28.

08-NCTC_59.

A1122

14-NCTC_87.

15-NCTC_87.

FV-1

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

Nairobi.

Nairobi.

Nairobi.

Nairobi.

Kenya?

Java .

Java; .

India; .

India; .

Bomb.

Type s.

Califor.

Probab.

Probab.

1963

1958

1958

1963

1939

1925

1920

1920

1928

1939

1939

1953

1953

PH 80/63

Yp2

13925/58

13927/58

PH 90/63

Tjiwidej

Yp1

Java

Bombay 2.

Parel

Bombay 1

Soemeda.

139 L

TS

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

.

10329 and 10330 from same.

10029 and 10030 from same.

10029 and 10030 from same.

10329 and 10330 from same.

received via Pasteur Institute .

patient from Maratha plague .

patient from Maratha plague .

Spermophilus beecheyi

sample received from India .

sample received from India .

Antiqua

Antiqua

Antiqua

Medievalis

Orientalis

Orientalis

Orientalis

Orientalis

Orientalis

Orientalis

Orientalis

Orientalis

Page 35: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

                                                                                                   

Microarrays

Page 36: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

Array Technology

High density oligonucleotide arrays

High density ‘spotted’ arrays

Low density ‘line-probe’ arrays

Low density addressable arrays

Page 37: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

   

 

Pathogenesis

  The CDC, NAID: SARS, smallpox  

   

 

Disease Susceptibility   “susceptibility genes” in HIV      

 

Vaccine Development   to examine transcriptional activity of all genes of pathogenic

microorganisms under in vivo conditions      

 

Pathogen Identification   Identify pathogens using ribosomal DNA sequences

     

 

Drug Response

 identify the presence of drug resistance genes catalog individual genetic variations in drug resistance

Page 38: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

Imagine a world where microscopic medical implants patrol our arteries, diagnosing ailments and fighting disease; where military battle-suits deflect explosions; where computer chips are no bigger than specks of dust; and where clouds of miniature space probes transmit data from the atmospheres of Mars or Titan.Many incredible claims have been made about the future's nanotechnological applications, but what exactly does nano mean, and why has controversy plagued this emerging technology?

Page 39: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

Nanotechnology is science and engineering at the scale of atoms and molecules. It is the manipulation and use of

materials and devices so tiny that nothing can be built any smaller.

Page 40: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

Water Soluble & Functional NIR Dyes

Fluorene Oligomer for Electronic Applications

Green Emission Quantum Dot

Page 41: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

Molecular diagnostics is becoming a driving force in drug development. Applications have spread

from identifying infections to include screening for cancer, hepatitis and genetic disorders

Personalised MedicineThe scientific community is progressing quite

rapidly in developing molecular diagnostics, and industry is developing assay prototypes and

conducting larger validation studies to advance this research to full clinical utility.

Page 42: Pathways of technology adoption and adaptation Saheer Gharbia Applied and Functional Genomics Centre for Infection Health Protection Agency.

The risk associated with the newer technologies is that the accuracy and precision of the data generated will be compromised. Highly specific assay formats are required to detect DNA sequence variations

To achieve such specificity, Careful assay design, Validation, Quality Control Standards are required


Recommended